SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!
BEIBEI
Lv3
220 积分
2022-05-13 加入
最近求助
最近应助
互助留言
877P Exploratory efficacy and translational results from the safety run in of AHEAD-MERIT, a phase II trial of first line pembrolizumab plus the fixed-antigen cancer vaccine BNT113 in advanced HPV16+ HNSCC
1个月前
已关闭
999MO HARE-40: A phase I/II trial of therapeutic HPV vaccine (BNT113) in patients with HPV16 driven carcinoma
1个月前
已关闭
The potential use of therapeutics and prophylactic mRNA vaccines in human papillomavirus (HPV)
1个月前
已完结
Acute acalculous cholecystitis following extended administration of nirmatrelvir/ritonavir for persistent SARS-CoV-2 infection
5个月前
已完结
Association of Antiviral Drugs for the Treatment of COVID-19 With Acute Renal Failure
5个月前
已完结
Pharmacist's role in the management of drug–drug interactions caused by nirmatrelvir/ritonavir in COVID-19 oncohematology patients
5个月前
已完结
Comparative analysis of the safety and effectiveness of Nirmatrelvir-Ritonavir and Azvudine in older patients with COVID-19: a retrospective study from a tertiary hospital in China
5个月前
已完结
[Translated article] Safety profile of nirmatrelvir-ritonavir: Evidence of adverse events due to DDIs
5个月前
已完结
Safety Profile of Paxlovid in the Treatment of COVID-19
5个月前
已完结
奈玛特韦/利托那韦对肾功能不全新型冠状病毒感染患者肾功能影响的临床观察
5个月前
已完结
没有进行任何应助
帮大忙了
1个月前
感谢
5个月前
感谢
5个月前
感谢
5个月前
感谢
5个月前
点赞
5个月前
感谢
5个月前
感谢
5个月前
感谢
5个月前
感谢
5个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论